• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors contributing to the hospitalization of patients with congestive heart failure.导致充血性心力衰竭患者住院的因素。
Am J Public Health. 1997 Apr;87(4):643-8. doi: 10.2105/ajph.87.4.643.
2
Correlates of major complications or death in patients admitted to the hospital with congestive heart failure.
Arch Intern Med. 1996 Sep 9;156(16):1814-20.
3
Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.血管紧张素转换酶抑制剂在因心力衰竭和左心室收缩功能障碍住院的老年患者中的应用。
Cardiology. 2005;103(1):17-23. doi: 10.1159/000081847. Epub 2004 Nov 2.
4
Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.医师在充血性心力衰竭住院治疗中使用血管紧张素转换酶抑制剂的模式。
J La State Med Soc. 1997 Dec;149(12):474-84.
5
A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.一项关于血管紧张素转换酶抑制剂对尼日利亚人充血性心力衰竭院内死亡率影响的三年临床回顾。
Cent Afr J Med. 1996 Aug;42(8):253-5.
6
Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.住院治疗对老年高血压患者使用血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的影响。
Aging Clin Exp Res. 2014 Jun;26(3):307-14. doi: 10.1007/s40520-014-0231-1. Epub 2014 Apr 30.
7
Incidence and predictors of development of acute renal failure related to treatment of congestive heart failure with ACE inhibitors.与使用血管紧张素转换酶抑制剂治疗充血性心力衰竭相关的急性肾衰竭的发生率及预测因素。
Nephron Clin Pract. 2007;105(2):c77-83. doi: 10.1159/000097658. Epub 2006 Dec 1.
8
Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.在肺动脉压力监测期间与心力衰竭住院减少相关的干预措施。
JACC Heart Fail. 2016 May;4(5):333-44. doi: 10.1016/j.jchf.2015.11.011. Epub 2016 Feb 10.
9
Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在充血性心力衰竭患者中的应用:治疗率和临床结局的观察性研究
Isr Med Assoc J. 2008 Mar;10(3):214-8.
10
Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.海地国立大学医院充血性心力衰竭的临床、超声心动图特征及预后
Am Heart J. 2016 Aug;178:151-60. doi: 10.1016/j.ahj.2016.06.001. Epub 2016 Jun 7.

引用本文的文献

1
Simultaneous Symptom Network Analysis of Heart Failure Patients: A Cross-Sectional Study.心力衰竭患者症状网络同步分析:一项横断面研究。
Risk Manag Healthc Policy. 2025 Jul 26;18:2493-2503. doi: 10.2147/RMHP.S520974. eCollection 2025.
2
Formative Perceptions of a Digital Pill System to Measure Adherence to Heart Failure Pharmacotherapy: Mixed Methods Study.用于测量心力衰竭药物治疗依从性的数字药丸系统的形成性认知:混合方法研究
JMIR Cardio. 2024 Feb 15;8:e48971. doi: 10.2196/48971.
3
Heart Failure With Preserved Ejection Fraction: An Evolving Understanding.射血分数保留的心力衰竭:不断发展的认识
Cureus. 2023 Sep 28;15(9):e46152. doi: 10.7759/cureus.46152. eCollection 2023 Sep.
4
Multidimensional Interventions on Supporting Disease Management for Hospitalized Patients with Heart Failure: The Role of Clinical and Community Pharmacists.针对住院心力衰竭患者支持疾病管理的多维干预措施:临床药师与社区药师的作用
J Clin Med. 2023 Apr 21;12(8):3037. doi: 10.3390/jcm12083037.
5
Sex-Specific Predictors of Long-Term Mortality in Elderly Patients with Ischemic Cardiomyopathy.老年缺血性心肌病患者长期死亡率的性别特异性预测因素
J Clin Med. 2023 Mar 3;12(5):2012. doi: 10.3390/jcm12052012.
6
Infection as an under-recognized precipitant of acute heart failure: prognostic and therapeutic implications.感染是急性心力衰竭被低估的促发因素:预后和治疗意义。
Heart Fail Rev. 2023 Jul;28(4):893-904. doi: 10.1007/s10741-023-10303-8. Epub 2023 Mar 10.
7
The predictive value of precipitating factors on clinical outcomes in hospitalized patients with decompensated heart failure: insights from the Egyptian cohort in the European Society of Cardiology Heart Failure long-term registry.诱发因素对失代偿性心力衰竭住院患者临床结局的预测价值:来自欧洲心脏病学会心力衰竭长期注册研究中埃及队列的见解
Egypt Heart J. 2023 Mar 8;75(1):16. doi: 10.1186/s43044-023-00342-9.
8
Seasonal and Secular Trends of Cardiovascular, Nutritional, and Inflammatory Markers in Patients on Hemodialysis.血液透析患者心血管、营养和炎症标志物的季节性和季节性趋势。
Kidney360. 2020 Jan 23;1(2):93-105. doi: 10.34067/KID.0000352019. eCollection 2020 Feb 27.
9
Food security, diet quality, nutritional knowledge, and attitudes towards research in adults with heart failure during the COVID-19 pandemic.COVID-19 大流行期间心力衰竭成年人的食品安全、饮食质量、营养知识和对研究的态度。
Clin Cardiol. 2022 Feb;45(2):180-188. doi: 10.1002/clc.23761. Epub 2022 Feb 2.
10
Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry.急性心力衰竭住院诱发因素的区域性差异:来自 REPORT-HF 注册研究的启示。
Eur J Heart Fail. 2022 Apr;24(4):645-652. doi: 10.1002/ejhf.2431. Epub 2022 Feb 17.

本文引用的文献

1
The factor of infection in heart failure.心力衰竭中的感染因素。
Br Med J. 1954 Oct 30;2(4845):1018-22. doi: 10.1136/bmj.2.4895.1018.
2
Correlates of major complications or death in patients admitted to the hospital with congestive heart failure.
Arch Intern Med. 1996 Sep 9;156(16):1814-20.
3
Concomitant factors of decompensation in chronic heart failure.慢性心力衰竭失代偿的伴随因素。
Am J Cardiol. 1996 Aug 1;78(3):354-7. doi: 10.1016/s0002-9149(96)00294-9.
4
Perspective of the pharmaceutical industry on the development of new drugs for heart failure.
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):198A-200A. doi: 10.1016/0735-1097(93)90491-i.
5
Epidemiology of heart failure in the United States.美国心力衰竭的流行病学
Am Heart J. 1993 Oct;126(4):1042-7. doi: 10.1016/0002-8703(93)90738-u.
6
Evidence of inadequate investigation and treatment of patients with heart failure.心力衰竭患者调查与治疗不足的证据。
Br Heart J. 1994 Jun;71(6):584-7. doi: 10.1136/hrt.71.6.584.
7
Reducing lengths of stay in the coronary care unit with a practice guideline for patients with congestive heart failure. Insights from a controlled clinical trial.
Med Care. 1994 Dec;32(12):1232-43. doi: 10.1097/00005650-199412000-00006.
8
Management of heart failure. II. Counseling, education, and lifestyle modifications.心力衰竭的管理。II. 咨询、教育及生活方式调整
JAMA. 1994 Nov 9;272(18):1442-6. doi: 10.1001/jama.1994.03520180066037.
9
The association between the quality of inpatient care and early readmission.住院护理质量与早期再入院之间的关联。
Ann Intern Med. 1995 Mar 15;122(6):415-21. doi: 10.7326/0003-4819-122-6-199503150-00003.
10
Patterns of medication use in patients with heart failure: a report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD).
South Med J. 1995 May;88(5):514-23. doi: 10.1097/00007611-199505000-00002.

导致充血性心力衰竭患者住院的因素。

Factors contributing to the hospitalization of patients with congestive heart failure.

作者信息

Chin M H, Goldman L

机构信息

Department of Medicine, Brigham and Women's Hospital, Boston, Mass, USA.

出版信息

Am J Public Health. 1997 Apr;87(4):643-8. doi: 10.2105/ajph.87.4.643.

DOI:10.2105/ajph.87.4.643
PMID:9146445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1380846/
Abstract

OBJECTIVES

This study identifies acute precipitants of hospitalization and evaluates utilization of angiotension-converting enzyme inhibitors in patients admitted with congestive heart failure.

METHODS

Cross-sectional chart-review study was done of 435 patients admitted nonelectively from February 1993 to February 1994 to an urban university hospital with a complaint of shortness of breath or fatigue and evidence of congestive heart failure.

RESULTS

The most common identifiable abnormalities associated with clinical deterioration prior to admission were acute anginal chest pain (33%), respiratory infection (16%), uncontrolled hypertension with initial systolic blood pressure > or = 180 mm Hg (15%), atrial arrhythmia with heart rate > or = 120 (8%), and noncompliance with medications (15%) or diet (6%); in 34% of patients, no clear cause could be identified. After exclusion of those who were already on a different vasodilator or who had relative contraindications, 18 (32%) of the patients with ejection fractions < or = 0.35 measured prior to admission were not taking an angiotensin-converting enzyme inhibitor on presentation to the hospital.

CONCLUSIONS

Interventions to improve compliance, the control of hypertension, and the appropriate use of angiotensin-converting enzyme inhibitors may prevent many hospitalizations of heart-failure patients.

摘要

目的

本研究旨在确定住院的急性诱发因素,并评估充血性心力衰竭患者血管紧张素转换酶抑制剂的使用情况。

方法

对1993年2月至1994年2月间因呼吸急促或疲劳主诉且有充血性心力衰竭证据而无选择性入住一家城市大学医院的435例患者进行横断面图表回顾研究。

结果

入院前与临床病情恶化相关的最常见可识别异常情况为急性心绞痛(33%)、呼吸道感染(16%)、初始收缩压≥180 mmHg的未控制高血压(15%)、心率≥120的房性心律失常(8%)以及药物治疗(15%)或饮食(6%)不依从;34%的患者未发现明确病因。排除那些已在使用其他血管扩张剂或有相对禁忌证的患者后,入院前测得射血分数≤0.35的患者中有18例(32%)在入院时未服用血管紧张素转换酶抑制剂。

结论

改善依从性、控制高血压以及合理使用血管紧张素转换酶抑制剂的干预措施可能预防许多心力衰竭患者的住院治疗。